Publications database

These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System. They reflect the requirements of Regulation (EC) No 1920/2006 (as amended) and Council...

This report includes estimates of the total size of the retail drug market in the European Union in 2017 for cannabis, heroin, cocaine, amphetamines and MDMA. This is a supporting publication to...

Xchange is an online registry of evidence-based prevention interventions. It is updated approximated twice a year with new programmes and feedback from implementers. The registry makes available manualised interventions for which good...

The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. A more recent version of this publication is...

This paper describes the significant developments that have occurred in the last 5 to 10 years in the field of drug precursors related to synthetic stimulant drugs produced in the EU. This...

This paper is part of the EMCDDA activity around the development and improvement of drug supply indicators, with a focus on drug-related homicide. It builds upon the 2017 review of the academic...

This short publication presents the main highlights from the EU Drug Markets Report 2019, targeting policy and practice.

This report provides a comprehensive overview of the methamphetamine market in the European Union. It assesses the current threat situation regarding current trends in production, trafficking and distribution. This is a supporting...

This paper explains the methodology developed by the EMCDDA for open-source information monitoring in the area of drug markets. Initially designed to support the work of the EU Early Warning System in...

Under international laws, cultivation, supply and possession of cannabis should be allowed only for ‘medical and scientific purposes’. In general, possession of the drug for personal use should be a crime, to...